{"paper_id":"bda03b60-3d84-4bda-9b87-69df5a501b9a","body_text":"Abstract #0436\nDOI: https://doi.org/10.58530/2023/0436\nEndometriosis targeted MRI imaging using bevacizumab-modified nanoparticles aiming at vascular endothelial growth factor\nQi Zhang1, Caixia Fu2, Qing Li3, and Yajie Li4\n1Department of Radiology, Huashan hospital, Fudan University, Shanghai, China, 2MR Application Development, Siemens Shenzhen Magnetic Resonance Ltd., Shenzhen, China, 3MR Collaborations, Siemens Healthineers Digital Technology (Shanghai) Co., Ltd., Shanghai, China, 4Fudan University, Shanghai, China\nSynopsis\nKeywords: Uterus, Molecular ImagingIn vivo, NPBCNs generated strong signal enhancement in endometriosis lesion in rat on T1-weighted images via MRI.\nHow to access this content:\nFor one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.\nAfter one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.\nAfter two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.\nClick here for more information on becoming a member.","source_license":"CC0","license_restricted":false}